Figure 2 Following intraperitoneal administration of CoQ 10 in rat, only small amount of the supplement reaches the kidney, muscle, and brain
[DOI] [PubMed] [Google Scholar] 29.Sankpal U.T., Abdelrahim M., Connelly S.F., Lee C.M., Madero-Visbal R., Colon J., Smith J., Safe S., Maliakal P., Basha R
Metabolism & Elimination The metabolic fate and degradation pathways of MOTS-c remain incompletely characterized, representing a significant gap in pharmacokinetic understanding: Rapid plasma clearance observed in preclinical models, though precise half-life not definitively established Likely degradation through peptidase activity, though specific enzymes not identified No accumulation detected in chronic administration studies (animal models) Active metabolites not characterized
They show promise as adjunctive therapy in sepsis due to their anti-inflammatory, antioxidant, and endothelial-protective actions
It was developed by Novo Nordisk and is sold under two main brand names